Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Sell
48
MDXG Quote, Financials, Valuation and Earnings
Last price:
$6.93
Seasonality move
:
8.81%
Day range:
$6.79 - $7.06
52-week range:
$5.79 - $10.14
Dividend yield:
0%
P/E ratio:
25.38x
P/S ratio:
2.63x
P/B ratio:
4.30x
Volume:
527.7K
Avg. volume:
1.1M
1-year change:
-26.82%
Market cap:
$1B
Revenue:
$348.9M
EPS (TTM):
$0.27
Analysts' Opinion
-
Consensus RatingMiMedx Group, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $12.20, MiMedx Group, Inc. has an estimated upside of 76.05% from its current price of $6.93.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $12.00 representing 100% downside risk from its current price of $6.93.
Fair Value
-
According to the consensus of 5 analysts, MiMedx Group, Inc. has 76.05% upside to fair value with a price target of $12.20 per share.
MDXG vs. S&P 500
-
Over the past 5 trading days, MiMedx Group, Inc. has overperformed the S&P 500 by 0.41% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
MiMedx Group, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
MiMedx Group, Inc. has grown year-over-year revenues for 13 quarters straight. In the most recent quarter MiMedx Group, Inc. reported revenues of $113.7M.
Earnings Growth
-
MiMedx Group, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter MiMedx Group, Inc. reported earnings per share of $0.11.
Enterprise value:
902.5M
EV / Invested capital:
3.51x
Price / LTM sales:
2.63x
EV / EBIT:
16.73x
EV / Revenue:
2.29x
PEG ratio (5yr expected):
--
EV / Free cash flow:
13.30x
Price / Operating cash flow:
15.26x
Enterprise value / EBITDA:
13.60x
Gross Profit (TTM):
$322.1M
Return On Assets:
14.7%
Net Income Margin (TTM):
10.38%
Return On Equity:
19.77%
Return On Invested Capital:
18.04%
Operating Margin:
19.51%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $309M | $342.8M | $393.4M | $84.1M | $113.7M | |
| Gross Profit | $253.1M | $285M | $322.1M | $68.5M | $94.9M | |
| Operating Income | $22.7M | $63.7M | $54M | $11.5M | $22.2M | |
| EBITDA | $26.6M | $66.7M | $66.4M | $12.2M | $27.5M | |
| Diluted EPS | -$0.04 | $0.59 | $0.27 | $0.05 | $0.11 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $140.2M | $136M | $154.5M | $172.1M | $254.1M | |
| Total Assets | $180.5M | $172.8M | $189M | $243.9M | $319M | |
| Current Liabilities | $41.7M | $45.9M | $43.6M | $41.9M | $57.7M | |
| Total Liabilities | $93.8M | $99.8M | $95.2M | $62.9M | $80M | |
| Total Equity | $86.7M | $73M | $93.8M | $181M | $238.9M | |
| Total Debt | $48M | $48.5M | $49M | $19M | $18.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $10.9M | $56.6M | $68.9M | $19.6M | $29.3M | |
| Cash From Investing | -$3.4M | -$7.3M | -$9.3M | $113K | -$5.3M | |
| Cash From Financing | $436K | -$41.6M | -$6.3M | $27K | -$857K | |
| Free Cash Flow | $7.5M | $54.6M | $67.9M | $19.7M | $29.1M | |
MDXG
Sector
Market Cap
$1B
$28.5M
Price % of 52-Week High
68.34%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
0.32%
-1.33%
1-Year Price Total Return
-26.82%
-20.32%
Beta (5-Year)
1.643
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$6.86
200-day SMA
Sell
Level
$7.01
Bollinger Bands (100)
Sell
Level
6.73 - 7.31
Chaikin Money Flow
Sell
Level
-2.3M
20-day SMA
Sell
Level
$7.01
Relative Strength Index (RSI14)
Sell
Level
48.85
ADX Line
Sell
Level
18.53
Williams %R
Neutral
Level
-48.9451
50-day SMA
Sell
Level
$7.00
MACD (12, 26)
Sell
Level
-0.08
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Sell
Level
-84.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (14.222)
Buy
CA Score
(Annual)
Level (1.9132)
Buy
Beneish M-Score
(Annual)
Level (-2.8465)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-2.6841)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
Stock Forecast FAQ
In the current month, MDXG has received 5 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MDXG average analyst price target in the past 3 months is $12.20.
-
Where Will MiMedx Group, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that MiMedx Group, Inc. share price will rise to $12.20 per share over the next 12 months.
-
What Do Analysts Say About MiMedx Group, Inc.?
Analysts are divided on their view about MiMedx Group, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MiMedx Group, Inc. is a Sell and believe this share price will drop from its current level to $12.00.
-
What Is MiMedx Group, Inc.'s Price Target?
The price target for MiMedx Group, Inc. over the next 1-year time period is forecast to be $12.20 according to 5 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MDXG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for MiMedx Group, Inc. is a Buy. 5 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MDXG?
You can purchase shares of MiMedx Group, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MiMedx Group, Inc. shares.
-
What Is The MiMedx Group, Inc. Share Price Today?
MiMedx Group, Inc. was last trading at $6.93 per share. This represents the most recent stock quote for MiMedx Group, Inc.. Yesterday, MiMedx Group, Inc. closed at $6.93 per share.
-
How To Buy MiMedx Group, Inc. Stock Online?
In order to purchase MiMedx Group, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get MDXG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MDXG
Sector
P/E ratio
25.38x
23.75x
PEG ratio
--
-0.01x
P/B ratio
4.30x
1.83x
Price / LTM sales
2.63x
1.60x
Growth Metrics
MDXG
Sector
Revenue growth
35.3%
4.85%
Earnings growth
104.95%
11.11%
Revenue (5-year growth)
3.12%
6.45%
Earnings forecast
$0.08
-$0.20
Profitability
MDXG
Sector
Profitability FY 2024
$287.2M
$3.6M
Return on invested capital
18.04%
-30.98%
Return on assets
14.7%
-27.62%
Return on equity
19.77%
-36.69%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Jan
28
Balance Sheet
MDXG
Sector
Total cash
$142.1M
$27.2M
Short term investments
--
$25.7M
Total assets
$263.9M
$79.7M
Long term debt
$18.2M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
